Information  X 
Enter a valid email address

ReNeuron Group PLC Ord 1P (RENE)

Date Time Source Announcement
17 Jul 2018 7:00 am
RNS
Notification of Major Holdings
  7:00 am
RNS
Notification of Major Holdings
16 Jul 2018 3:39 pm
RNS
Notification of Major Holdings
  7:00 am
RNS
Notification of Major Holdings
  7:00 am
RNS
Notification of Major Holdings
13 Jul 2018 11:50 am
RNS
Notification of Major Holdings
  11:50 am
RNS
Notification of Major Holdings
12 Jul 2018 7:00 am
RNS
Preliminary Results
11 Jul 2018 7:00 am
RNS
Signs retinal stem cell exclusivity agreement
04 Jul 2018 2:15 pm
RNS
Notification of Preliminary Results
17 May 2018 7:00 am
RNS
Capital Markets Event
04 May 2018 7:00 am
RNS
Exosome data presented at ISCT conference
30 Apr 2018 7:00 am
RNS
Capital Markets Event and Webcast
19 Apr 2018 7:00 am
RNS
Wins grant for retinal cell therapy development
10 Apr 2018 1:00 pm
RNS
Appointment of US-based Chief Medical Officer
26 Mar 2018 7:00 am
RNS
Product Development Update
01 Mar 2018 7:00 am
RNS
Block Listing Review and TVR
16 Feb 2018 7:00 am
RNS
Block Listing Application
13 Feb 2018 10:00 am
RNS
Positive pre-clinical data in nerve injury
26 Jan 2018 7:00 am
RNS
Phase II stroke data presented at AHA conference
23 Jan 2018 11:06 am
RNS
Approval of Share Capital Reorganisation
11 Jan 2018 7:00 am
RNS
Further re Share Capital Reorganisation
05 Jan 2018 7:00 am
RNS
Proposed Share Capital Reorganisation
14 Dec 2017 7:00 am
RNS
Interim results
  7:00 am
RNS
Stroke clinical trial regulatory approval in US
08 Dec 2017 7:00 am
RNS
ReNeuron opens US office
13 Nov 2017 11:30 am
RNS
Notification of Interim Results
08 Nov 2017 7:00 am
RNS
Retinal disease clinical trial moves into Phase II
31 Oct 2017 7:00 am
RNS
Positive stroke clinical data & regulatory update
27 Oct 2017 7:00 am
RNS
Wins further UK grant
11 Oct 2017 1:31 pm
RNS
PDMR Interest in Shares and Share Options
09 Oct 2017 7:00 am
RNS
Presentation of positive pre-clinical data
12 Sep 2017 7:00 am
RNS
Directors' Interest in Shares and Share Options
06 Sep 2017 11:15 am
RNS
Result of AGM
  7:00 am
RNS
AGM Trading Update
01 Sep 2017 7:00 am
RNS
Non-executive Director Appointment
  7:00 am
RNS
Block Listing Review and TVR
07 Aug 2017 3:04 pm
RNS
Posting of Annual Report and Notice of AGM
04 Aug 2017 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
25 Jul 2017 7:00 am
RNS
Appointment of joint broker
19 Jul 2017 7:00 am
RNS
Board change
29 Jun 2017 7:00 am
RNS
Preliminary Results
19 Jun 2017 7:00 am
RNS
FDA approves cryopreserved hRPC formulation
08 Jun 2017 7:00 am
RNS
Notification of Preliminary Results
05 Jun 2017 7:00 am
RNS
Positive FDA feedback on proposed Phase III study
18 May 2017 7:00 am
RNS
Presents positive exosome data at major conference
11 May 2017 7:00 am
RNS
Awarded major UK cell therapy manufacturing grant
05 May 2017 7:00 am
RNS
Presents new exosome data at major conference
21 Apr 2017 7:01 am
RNS
Update on clinical strategy in stroke disability
  7:00 am
RNS
Update on progress in ophthalmology programmes
01 Mar 2017 7:00 am
RNS
Block Listing Review and Total Voting Rights
15 Feb 2017 7:00 am
RNS
ReNeuron featured in BBC documentary
07 Feb 2017 12:32 pm
RNS
Director Share Purchase
14 Dec 2016 12:15 pm
RNS
Director Share Purchase
05 Dec 2016 7:00 am
RNS
Reports Positive Results in Phase II Stroke Trial
  7:00 am
RNS
Interim Results
14 Nov 2016 7:00 am
RNS
Notification of Interim Results
05 Oct 2016 2:30 pm
RNS
Notification of Major Interest in Shares
  2:30 pm
RNS
Notification of Major Interest in Shares
 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t